# Acthar for Treatment of Post-transplant FSGS

> **NCT02399462** · PHASE4 · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- FSGS
- Renal Transplantation
- Kidney Transplantation

## Interventions

- **DRUG:** Acthar

## Key facts

- **NCT ID:** NCT02399462
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding terminated prematurely
- **Last updated:** 2021-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02399462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02399462, "Acthar for Treatment of Post-transplant FSGS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02399462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*